Insiders · Profile

Pinto Joshua

President at Neumora Therapeutics. Filing since 22 Aug 2024. CIK 0001992595

Company

Date

Role

Action

Amount

Of holding

NMRA Neumora Therapeutics, Inc.

17 Feb 2026

President

Sold at will

5,967

$21.09K

9.4%

NMRA Neumora Therapeutics, Inc.

18 Feb 2025

President

Sold on a plan

8,048

$13.48K

9.5%

NMRA Neumora Therapeutics, Inc.

27 Aug 2024

Chief Financial Officer

Sold on a plan

15,693

$178.81K

10.1%

NMRA Neumora Therapeutics, Inc.

26 Aug 2024

Chief Financial Officer

Sold on a plan

31,642

$372.59K

17.0%

NMRA Neumora Therapeutics, Inc.

23 Aug 2024

Chief Financial Officer

Sold on a plan

24,169

$280.01K

11.5%

NMRA Neumora Therapeutics, Inc.

22 Aug 2024

Chief Financial Officer

Sold on a plan

28,496

$331.47K

11.9%

6 decisions on file.